DIA
HBIO icon

Denver Investment Advisors’s Harvard Bioscience HBIO Stock Holding History

Denver Investment Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,588
Closed -$43K – 480
2016
Q3 		$43K Sell
1,588
-114
-7% -$3.17K ﹤0.01% 439
2016
Q2 		$49K Sell
1,702
-357
-17% -$11.4K ﹤0.01% 452
2016
Q1 		$62K Sell
2,059
-653
-24% -$18.5K ﹤0.01% 455
2015
Q4 		$94K Sell
2,712
-307
-10% -$10.5K ﹤0.01% 488
2015
Q3 		$114K Sell
3,019
-104
-3% -$4.84K 0.01% 497
2015
Q2 		$178K Buy
+3,123
New +$178K 0.01% 507

Other funds holding HBIO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPC
Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Denver Investment Advisors's HBIO Position: Q4 2016 in Review

Denver Investment Advisors sold out of Harvard Bioscience (HBIO) in Q4 2016, closing a stake of 1,588 shares — an estimated $43K sold.

Denver Investment Advisors first reported a position in HBIO in Q2 2015 and held it in 6 quarters. The position peaked at $178K in Q2 2015. 68 funds tracked by Wall St. Rank hold HBIO as of Q4 2016.

  • Denver Investment Advisors reported no remaining Harvard Bioscience position as of Q4 2016 after selling out during the quarter.
  • Denver Investment Advisors sold 1,588 Harvard Bioscience shares in Q4 2016, an estimated $43K.
  • Denver Investment Advisors first reported a position in Harvard Bioscience in Q2 2015 and held it in 6 quarters.
  • Denver Investment Advisors's Harvard Bioscience position peaked at $178K in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2016.

Based on Denver Investment Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.